1fls

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
The high-resolution solution structure of the catalytic fragment of human, collagenase-3 (MMP-13) complexed with a sulfonamide derivative of a, hydroxamic acid compound (WAY-151693) has been determined by, multidimensional heteronuclear NMR. A total of 30 structures were, calculated for residues 7-164 by means of hybrid distance, geometry-simulated annealing using a total of 3280 experimental NMR, restraints. The atomic rms distribution about the mean coordinate, positions for the 30 structures is 0.43(+/-0.05) A for the backbone atoms, 0.80(+/-0.09) A for all atoms, and 0.47(+/-0.04) A for all atoms excluding, disordered side-chains. The overall structure of MMP-13 is composed of a, beta-sheet consisting of five beta-strands in a mixed parallel and, anti-parallel arrangement and three alpha-helices where its overall fold, is consistent with previously solved MMP structures. A comparison of the, NMR structure of MMP-13 with the published 1.6 A resolution X-ray, structure indicates that the major differences between the structures is, associated with loop dynamics and crystal-packing interactions. The, side-chains of some active-site residues for the NMR and X-ray structures, of MMP-13 adopt distinct conformations. This is attributed to the presence, of unique inhibitors in the two structures that encounter distinct, interactions with MMP-13. The major structural difference observed between, the MMP-13 and MMP-1 NMR structures is the relative size and shape of the, S1' pocket where this pocket is significantly longer for MMP-13, nearly, reaching the surface of the protein. Additionally, MMP-1 and MMP-13, exhibit different dynamic properties for the active-site loop and the, structural Zn-binding region. The inhibitor WAY-151693 is well defined in, the MMP-13 active-site based on a total of 52 distance restraints. The, binding motif of WAY-151693 in the MMP-13 complex is consistent with our, previously reported MMP-1:CGS-27023A NMR structure and is similar to the, MMP-13: RS-130830 X-ray structure.
+
The high-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a sulfonamide derivative of a hydroxamic acid compound (WAY-151693) has been determined by multidimensional heteronuclear NMR. A total of 30 structures were calculated for residues 7-164 by means of hybrid distance geometry-simulated annealing using a total of 3280 experimental NMR restraints. The atomic rms distribution about the mean coordinate positions for the 30 structures is 0.43(+/-0.05) A for the backbone atoms, 0.80(+/-0.09) A for all atoms, and 0.47(+/-0.04) A for all atoms excluding disordered side-chains. The overall structure of MMP-13 is composed of a beta-sheet consisting of five beta-strands in a mixed parallel and anti-parallel arrangement and three alpha-helices where its overall fold is consistent with previously solved MMP structures. A comparison of the NMR structure of MMP-13 with the published 1.6 A resolution X-ray structure indicates that the major differences between the structures is associated with loop dynamics and crystal-packing interactions. The side-chains of some active-site residues for the NMR and X-ray structures of MMP-13 adopt distinct conformations. This is attributed to the presence of unique inhibitors in the two structures that encounter distinct interactions with MMP-13. The major structural difference observed between the MMP-13 and MMP-1 NMR structures is the relative size and shape of the S1' pocket where this pocket is significantly longer for MMP-13, nearly reaching the surface of the protein. Additionally, MMP-1 and MMP-13 exhibit different dynamic properties for the active-site loop and the structural Zn-binding region. The inhibitor WAY-151693 is well defined in the MMP-13 active-site based on a total of 52 distance restraints. The binding motif of WAY-151693 in the MMP-13 complex is consistent with our previously reported MMP-1:CGS-27023A NMR structure and is similar to the MMP-13: RS-130830 X-ray structure.
==About this Structure==
==About this Structure==
Line 13: Line 13:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Chanda, P.K.]]
+
[[Category: Chanda, P K.]]
-
[[Category: Chen, J.M.]]
+
[[Category: Chen, J M.]]
[[Category: Cosmi, S.]]
[[Category: Cosmi, S.]]
[[Category: Edris, W.]]
[[Category: Edris, W.]]
-
[[Category: Levin, J.I.]]
+
[[Category: Levin, J I.]]
-
[[Category: Moy, F.J.]]
+
[[Category: Moy, F J.]]
[[Category: Powers, R.]]
[[Category: Powers, R.]]
[[Category: CA]]
[[Category: CA]]
Line 28: Line 28:
[[Category: mmp-13]]
[[Category: mmp-13]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 15:48:13 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:40:02 2008''

Revision as of 10:40, 21 February 2008


1fls

Drag the structure with the mouse to rotate

SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR

Overview

The high-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a sulfonamide derivative of a hydroxamic acid compound (WAY-151693) has been determined by multidimensional heteronuclear NMR. A total of 30 structures were calculated for residues 7-164 by means of hybrid distance geometry-simulated annealing using a total of 3280 experimental NMR restraints. The atomic rms distribution about the mean coordinate positions for the 30 structures is 0.43(+/-0.05) A for the backbone atoms, 0.80(+/-0.09) A for all atoms, and 0.47(+/-0.04) A for all atoms excluding disordered side-chains. The overall structure of MMP-13 is composed of a beta-sheet consisting of five beta-strands in a mixed parallel and anti-parallel arrangement and three alpha-helices where its overall fold is consistent with previously solved MMP structures. A comparison of the NMR structure of MMP-13 with the published 1.6 A resolution X-ray structure indicates that the major differences between the structures is associated with loop dynamics and crystal-packing interactions. The side-chains of some active-site residues for the NMR and X-ray structures of MMP-13 adopt distinct conformations. This is attributed to the presence of unique inhibitors in the two structures that encounter distinct interactions with MMP-13. The major structural difference observed between the MMP-13 and MMP-1 NMR structures is the relative size and shape of the S1' pocket where this pocket is significantly longer for MMP-13, nearly reaching the surface of the protein. Additionally, MMP-1 and MMP-13 exhibit different dynamic properties for the active-site loop and the structural Zn-binding region. The inhibitor WAY-151693 is well defined in the MMP-13 active-site based on a total of 52 distance restraints. The binding motif of WAY-151693 in the MMP-13 complex is consistent with our previously reported MMP-1:CGS-27023A NMR structure and is similar to the MMP-13: RS-130830 X-ray structure.

About this Structure

1FLS is a Single protein structure of sequence from Homo sapiens with , and as ligands. Full crystallographic information is available from OCA.

Reference

High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor., Moy FJ, Chanda PK, Chen JM, Cosmi S, Edris W, Levin JI, Powers R, J Mol Biol. 2000 Sep 22;302(3):671-89. PMID:10986126

Page seeded by OCA on Thu Feb 21 12:40:02 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools